StreetInsider.com News Articles

Form 424B3 AIM ImmunoTech Inc.

Thu, 18 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260618/26665942.html

Form 424B3 AIM ImmunoTech Inc.

Thu, 18 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260618/26665942.html

AIM ImmunoTech (AIM) files for 13.08M share offering by selling stockholders

Thu, 18 Jun 2026 08:06:39 -0400

AIM ImmunoTech (NYSE: AIM) has filed for up to 13,077,089 share offering by selling stockholders.

AIM ImmunoTech (AIM) files for 13.08M share offering by selling stockholders

Thu, 18 Jun 2026 08:06:39 -0400

AIM ImmunoTech (NYSE: AIM) has filed for up to 13,077,089 share offering by selling stockholders.

Form S-1 AIM ImmunoTech Inc.

Thu, 18 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260618/26663121.html

Form S-1 AIM ImmunoTech Inc.

Thu, 18 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260618/26663121.html

Form EFFECT AIM ImmunoTech Inc.

Wed, 17 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260617/26656425.html

Form EFFECT AIM ImmunoTech Inc.

Wed, 17 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260617/26656425.html

Form PRE 14A AIM ImmunoTech Inc. For: Jun 15

Mon, 15 Jun 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260615/26648707.html

Form PRE 14A AIM ImmunoTech Inc. For: Jun 15

Mon, 15 Jun 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260615/26648707.html

Form 8-K AIM ImmunoTech Inc. For: Jun 12

Mon, 15 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26644476.html

Form 8-K AIM ImmunoTech Inc. For: Jun 12

Mon, 15 Jun 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260615/26644476.html

Form 8-K AIM ImmunoTech Inc. For: Jun 09

Thu, 11 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260611/26635867.html

Form 8-K AIM ImmunoTech Inc. For: Jun 09

Thu, 11 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260611/26635867.html

Form 8-K AIM ImmunoTech Inc. For: Jun 09

Wed, 10 Jun 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260610/26630691.html

Form 8-K AIM ImmunoTech Inc. For: Jun 09

Wed, 10 Jun 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260610/26630691.html

Form 424B5 AIM ImmunoTech Inc.

Wed, 10 Jun 2026 14:01:00 -0400

si-local-file:///var/storage/secattach/20260610/26629249.html

Form 424B5 AIM ImmunoTech Inc.

Wed, 10 Jun 2026 14:01:00 -0400

si-local-file:///var/storage/secattach/20260610/26629249.html

AIM ImmunoTech raises $2.65 million in registered direct offering

Tue, 09 Jun 2026 09:30:49 -0400

AIM ImmunoTech Inc. (NYSE American: AIM) announced it entered into definitive agreements for a registered direct offering and concurrent private placement that will generate approximately $2.65 million in gross proceeds before deducting placement agent commissions and other offering expenses.

The offering is expected to close on or about June 10, 2026, subject to customary closing conditions. Ladenburg Thalmann & Co. Inc. serves as the exclusive placement agent for the transaction.

Under the terms, AIM ImmunoTech will issue 2,554,119 shares of common stock at $0.5189 per share in the registered direct offering. The concurrent private placement will include an equal number of unregistered

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Tue, 09 Jun 2026 09:29:00 -0400

OCALA, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it has entered into definitive agreements for a registered direct offering and concurrent private placement priced at-the-market under NYSE American rules for gross proceeds of approximately $2.65 million, before deducting placement agent commissions and other offering expenses.

Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.

The offering is expected to close on or about June 10, 2026, subject to the satisfaction of customary closing conditions.

In the registered

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Tue, 09 Jun 2026 09:29:00 -0400

Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.

The offering is expected to close on or about June 10, 2026, subject to the satisfaction of customary closing conditions.

In the registered

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Tue, 09 Jun 2026 09:29:00 -0400

Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.

The offering is expected to close on or about June 10, 2026, subject to the satisfaction of customary closing conditions.

In the registered

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Tue, 09 Jun 2026 09:29:00 -0400

Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.

The offering is expected to close on or about June 10, 2026, subject to the satisfaction of customary closing conditions.

In the registered

AIM ImmunoTech (AIM) Halted, News Pending

Tue, 09 Jun 2026 09:27:26 -0400

AIM ImmunoTech (NYSE: AIM) Halted, News Pending

AIM ImmunoTech (AIM) files for 31.3M share offering by selling stockholders

Mon, 08 Jun 2026 16:08:19 -0400

AIM ImmunoTech (NYSE: AIM) has filed for up to 31,287,933 share offering by selling stockholders.